Skip to main content

Illinois IGB

Tumor

AI in Cancer Research: Tumor Phylogenetics

September 15, 2021

Artificial intelligence is often employed in the field of cancer genomics, where bits of DNA sequencing data must be identified and further analyzed with statistical, evolutional, and probabilistic models. “Off-the-shelf” computing tools are useful for many cancer researchers, but Mohammed El-Kebir (IGOH), Cancer Center at Illinois (CCIL) scientist, is taking these AI applications a step further.


September 15, 2021


Related Articles

Drugs reprogram genes in breast tumors to prevent endocrine resistance

April 23, 2019

Treating breast tumors with two cancer drugs simultaneously may prevent endocrine resistance by attacking the disease along two separate gene pathways, scientists at the University of Illinois found in a new study.

The two drugs used in the study, selinexor and 4-OHT, caused the cancer cells to die and tumors to regress for prolonged periods, said food science and human nutrition professor Zeynep Madak-Erdogan (ONC-PM), the principal investigator on the study.


April 23, 2019


Related Articles

Shape of tumor may affect whether cells can metastasize

April 28, 2016

Only a few cells in a cancerous tumor are able to break away and spread to other parts of the body, but the curve along the edge of the tumor may play a large role in activating these tumor-seeding cells, according to a new University of Illinois study.


April 28, 2016


Related Articles

Subscribe to Tumor